COMPANY

Doceree

Doceree is a healthcare adtech platform for pharma, publishers and HCP targeting.

Analyst Perspective

Doceree is a private healthcare advertising technology company focused on connecting pharmaceutical marketers and agencies with healthcare professional audiences across clinical workflows, specialist medical publishers and related healthcare media environments. Its product suite includes programmatic buying tools, an ad server for healthcare publishers, HCP data and audience products, a marketplace for audience activation, and conversational and point-of-care messaging solutions tailored to regulated healthcare settings. The company generates revenue from media spend flowing through its healthcare advertising products, software access for publisher and advertiser tools, and data activation or usage fees tied to HCP audience intelligence. Its direct customers are pharmaceutical brands, healthcare marketers, agencies, programmatic buyers and healthcare publishers, rather than end consumers.

Analyst Signal Briefing

Updated: 2 Jul 2026

Doceree has restructured its executive leadership, elevating Kamya Elawadhi to Co-Founder and President whilst appointing new Chief AI, Innovation, and Business Development Officers. These hires underpin the July 2026 launch of Daily Command, an AI-powered command centre for pharmaceutical teams co-developed with industry partners including Avalere Health. The company also relocated its UK office to King’s Cross and continues to advocate for agile omnichannel frameworks and the integration of AI to enhance the precision of healthcare marketing campaigns.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

Doceree is a healthcare-focused advertising technology company, not a general electronic health record vendor or a pharmaceutical manufacturer. It is distinct from broad horizontal adtech platforms because its products are built around HCP targeting, clinical workflows and regulated healthcare media.

Doceree: About

Doceree operates a vertical adtech model for healthcare. It creates value by aggregating regulated healthcare media supply, clinical workflow access and HCP audience data, then packaging these capabilities into software and activation products for pharmaceutical advertisers, agencies and healthcare publishers. On the demand side, it enables campaign targeting, activation and measurement. On the supply side, it helps healthcare publishers monetise inventory. The business combines platform software, proprietary data assets and transaction-enabled media activation.

How Doceree Works & Monetises

Business model analysis and core revenue streams

Doceree monetises through a blended model of programmatic media spend, SaaS-style platform fees and data activation revenue. Pharmaceutical advertisers and agencies pay for targeted campaign delivery and audience activation, likely on CPM-based and media budget-linked pricing. Healthcare publishers can pay for or share economics around ad management and monetisation tooling. Data-oriented products such as HCP audience intelligence and marketplace access support usage-based, licensing or pay-as-you-go fees. Premium pricing is also supported by regulated point-of-care and clinical workflow integrations.

Revenue Channels

Programmatic campaign spend from pharma advertisers and agenciesPercentage take-rate on media activation
Publisher monetisation and ad management platform accessSaaS / software subscription
HCP audience data and activationUsage-based data fees
Audience marketplace transactionsPay-as-you-go marketplace pricing
Conversational and premium point-of-care placementsPremium media and platform fees

Side-by-Side Comparisons

Compare Doceree directly with top competitors

Doceree: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (Doceree)

AdweekJun 25, 2026

Healthcare Marketing Embraces Agile Omnichannel and AI

At an Adweek House Cannes panel co-hosted with Doceree, healthcare marketing leaders discussed the need to move beyond traditional, linear planning toward more responsive, agile omnichannel frameworks. Panelists — including executives from Doceree, Publicis Health Media, Good Apple, Real Chemistry Media, Digitas Health and Novo Nordisk — argued that annual plans and vanity metrics (clicks, impressions) are insufficient for evolving provider and patient journeys. They emphasized aligning content strategies for prescribers and consumers, granting greater organizational and agency autonomy to speed decision-making, and incorporating AI tools to accelerate creative cycles and better predict future patient and provider behavior. The conversation highlighted rising importance of intent measurement in prescription decisions and the convergence of provider and patient content strategies.

Read original source
DocereeJun 20, 2026

Leadership Changes at Doceree

Kamya Elawadhi has been elevated to Co-Founder & President in February 2026, and Vijay Adapala has been appointed as Chief Business Development Officer in 2026. Additionally, new executives such as Julius Ramirez (Chief Partnerships Officer), Yeshwanth Srinivasan (Chief AI Officer), and Graham Wilkinson (Chief Innovation Officer) have joined the leadership team.

Read original source
AdExchangerJun 12, 2026

Viant Launches VPS; TAG Accreditation Loses Support

Viant has launched Viant Publisher Solutions (VPS), a publisher data feed and dashboard that gives DSP-side feedback on inventory performance and establishes a direct pipeline between Viant’s DSP and media companies, bypassing SSPs. Pilot partners are primarily in CTV and include Tubi, LG Ads, TCL, Scripps, A+E Networks and Xumo. The piece also reports that Google and The Trade Desk chose not to renew their Trusted Accountability Group (TAG) accreditations and that Procter & Gamble has stopped contractually requiring TAG accreditation. Separately, OpenAI is reportedly considering a significant reduction in token pricing, a move that could affect AI usage economics. The roundup includes several hiring and other industry notes (Doceree, Upworthy, The Trade Desk).

Read original source

Doceree: Frequently Asked Questions

What is Doceree?

Doceree is a healthcare advertising technology company that helps pharmaceutical marketers, agencies and healthcare publishers target and monetise healthcare professional audiences across clinical and digital environments.

Who uses Doceree?

Its users are mainly pharmaceutical brands, healthcare marketing teams, media agencies, programmatic buyers and healthcare publishers or media owners.

How does Doceree make money?

It makes money through programmatic media spend, platform and software fees, and data activation or usage fees tied to healthcare audience products and workflow integrations.

Company Facts

Founded
2020
Headquarters
150 John F Kennedy Pkwy, Suite 403, Short Hills, NJ 07078
Core Segment
AdTech Vendor
Company Size
201–500
Official Link
doceree.com